Müller-Gärtner H W, Baisch H, Wiegel T, Kremer B, Schneider C
Department of Nuclear Medicine, University of Hamburg, West Germany.
J Clin Endocrinol Metab. 1989 Jan;68(1):39-45. doi: 10.1210/jcem-68-1-39.
The percentage of cells in the S/G2M fraction and the cytosol deoxythymidine kinase activity (TKA) were measured in autonomously functioning thyroid adenomas (AFTA) and paranodular tissue (PNT), with special regard to the impact of the patient's serum TSH concentration on DNA synthesis. The S/G2M fraction was determined by means of DNA flow cytometry, and TKA was determined by radioenzyme assay. The S/G2M fraction of AFTA (n = 15, median; 7.1%; range, 3.2-9.2%) exceeded the S/G2M fraction of normal thyroid tissue (n = 8; median, 2.8%; range, 2.3-4.0%; P = 0.008) and in 12 of 13 AFTA was 1.2- to 2.3-fold higher than the S/G2M fraction in the corresponding PNT (median, 4.0%; range, 2.5-6.7%; P = 0.0022). TKA of AFTA (n = 15; median, 681 microIU/mg; range, 432-854 microIU/mg) exceeded TKA of normal thyroid tissue (n = 8; median, 356 microIU/mg; range, 194-426 microIU/mg; P = 0.0001) and was 1.1- to 4.2-fold increased compared with TKA activity in the corresponding PNT (median, 430 microIU/mg; range, 162-570 microIU/mg; P = 0.001). In the absence of measurable serum TSH there was a constant increase in the S/G2M fractions and the TKA in AFTA vs. those in PNT. In patients treated with methimazole with serum TSH concentrations of 0.5 mIU/L or more, the S/G2M fraction and TKA in both AFTA and PNT were significantly higher than those in untreated patients with serum TSH concentrations of 0.5 mIU/L or less. In the majority of AFTA, functional autonomy and increased DNA synthesis are concomitant phenomena. Although TSH may stimulate DNA synthesis in both AFTA and PNT, measurable serum TSH concentrations are apparently not essential for DNA synthesis.
在自主功能性甲状腺腺瘤(AFTA)和结节旁组织(PNT)中测量了处于S/G2M期的细胞百分比和胞质脱氧胸苷激酶活性(TKA),特别关注患者血清促甲状腺激素(TSH)浓度对DNA合成的影响。通过DNA流式细胞术测定S/G2M期细胞比例,通过放射酶法测定TKA。AFTA的S/G2M期细胞比例(n = 15,中位数;7.1%;范围,3.2 - 9.2%)超过正常甲状腺组织的S/G2M期细胞比例(n = 8;中位数,2.8%;范围,2.3 - 4.0%;P = 0.008),并且在13个AFTA中有12个的S/G2M期细胞比例比相应PNT中的S/G2M期细胞比例高1.2至2.3倍(中位数,4.0%;范围,2.5 - 6.7%;P = 0.0022)。AFTA的TKA(n = 15;中位数,681 mIU/mg;范围,432 - 854 mIU/mg)超过正常甲状腺组织的TKA(n = 8;中位数,356 mIU/mg;范围,194 - 426 mIU/mg;P = 0.0001),并且与相应PNT中的TKA活性相比增加了1.1至4.2倍(中位数,430 mIU/mg;范围,162 - 570 mIU/mg;P = 0.001)。在没有可测量血清TSH的情况下,AFTA中S/G2M期细胞比例和TKA相对于PNT中的持续增加。在接受甲巯咪唑治疗且血清TSH浓度为0.5 mIU/L或更高的患者中,AFTA和PNT中的S/G2M期细胞比例和TKA均显著高于血清TSH浓度为0.5 mIU/L或更低的未治疗患者。在大多数AFTA中,功能自主性和DNA合成增加是伴随出现的现象。虽然TSH可能刺激AFTA和PNT中的DNA合成,但可测量的血清TSH浓度显然不是DNA合成所必需的。